SweetBio® at 10: A Decade of Innovation, Resilience, and What’s Next
A decade ago, my brother, Isaac, and I founded SweetBio® with a bold vision: to make advanced wound care affordable and accessible to all. What started as an idea fueled by science and purpose has evolved beyond our wildest imagination with a growing impact across the U.S.
Today, SweetBio® is at an inflection point. With $10 million raised, patents in 18 countries, and 10 sales partners nationwide, we’re ready to scale like never before. But our journey wasn’t overnight—it was built on persistence, innovation, and, most importantly, putting people first.
– Kayla Rodriguez Graff, Co-Founder & CEO
5 Milestones That Shaped Our Journey
FDA Clearance – Approved for wounds across the body
Medicare Coverage – Making top-tier care more accessible and affordable
Global Innovation – Patents in 18 countries
Clinical Excellence – Positive randomized controlled trial + peer-reviewed publications
Thousands of Lives Touched – Helping patients and their loved ones recover better
5 Lessons from 10 Years in Biotech
Building a Foundation Takes Time
We spent years perfecting our technology, getting the right ‘yes’s, securing regulatory clearances, confirming a top-performing technology through peer-reviewed clinical publications, and assembling a team of mission-driven experts. That groundwork set the stage for where we are today—poised for exponential growth.
Health Equity Must Be a Priority
The wound care market is projected to surpass $27.2 billion by 2027, yet access to high-quality treatment remains out of reach for many. We founded SweetBio® to close this gap, ensuring that life-changing care isn’t a luxury, but a right.
Raising Capital Is About the Right Partners
Securing $10 million wasn’t just about funding—it was about finding investors who believe in our mission to transform wound care. The right capital fuels impact, not just growth.
Innovation Is a Marathon, Not a Sprint
From R&D to clinical validation, regulatory clearances to market entry, biotech is a long game. Success comes from persistence, adaptability, and an unwavering belief in the vision.
People First, Always
Our patients, providers, and team are at the heart of everything we do. Every decision we make—whether it’s designing our products or expanding our distribution—is rooted in serving people better.
5 Exciting Things Ahead
Scaling Nationwide
In collaboration with our wound supply partners, we have shared our story with their 200 account managers and sales representatives, enabling us to rapidly expand awareness and access to our VERIS™ and APIS® products. As we grow with top-tier partners, we're also gathering valuable feedback to continuously enhance our patient-first solutions.
Expanding Our Impact in Wound Care
Raising awareness about VERIS™ is our top priority so that more patients and families can have the opportunity of a healthier tomorrow.
Stronger Community Impact
We will continue breaking barriers in biotech, supporting underrepresented founders, and advocating for health equity.
Global Expansion
With patents in 18 countries, we’re looking beyond the U.S. to bring SweetBio®’s solutions to the world.
A Future Driven by Purpose
Our commitment to effective, affordable wound care is engrained in our DNA. As we accelerate into this next chapter, our vision holds steady: so healthier tomorrows can start today.
A decade ago, we started with an audacious vision—re-envisioning trusted ingredients, collagen and Manuka honey, to transform wound recovery. We set out to make healing simpler, better, and more affordable for millions. Today, our persistence and passion are reflected in every patient story, every healed wound, and every life changed. Together, we have empowered patients to take control of their recovery, and I am even more energized about the road ahead.
Thank you for 10 incredible years.
Be Part of the Movement
Patients: Struggling with a chronic wound or have an upcoming skin cancer removal surgery? Ask your doctor about VERIS™ for wound recovery.
Doctors: Learn more here.